logo
Sleep tight: are you getting enough to help ward off health issues?

Sleep tight: are you getting enough to help ward off health issues?

Irish Times20-05-2025

A good night's sleep isn't just about the number of hours you log. Getting quality sleep – the kind that leaves you feeling refreshed and ready for the day – is critical for a healthy brain.
People with disturbed sleep, because of something such as insomnia or sleep apnoea, have a higher risk of developing dementia than those with no sleep issues. Poor sleep can harm your brain in other ways, too.
One study found
that people in their 30s and 40s with heavily disrupted sleep (such as frequent awakenings or movements) were two to three times more likely to test lower in executive function, working memory and processing speeds a decade or so later.
Scientists think that deep sleep and rapid eye movement (or REM) sleep are particularly influential when it comes to brain health and dementia risk.
A study published this year
on people with deep sleep and REM deficiencies found that the subjects' brains showed signs of atrophy in MRI scans 13-17 years after the deficiencies were observed; the atrophy looked similar to what you'd find in the early stages of Alzheimer's disease.
What scientists know
When you're asleep, your brain continuously cycles through four distinct phases: two stages of lighter sleep, when your body relaxes and your heart rate and temperature drop; deep sleep or slow-wave sleep, when brain activity slows; and REM, when you typically dream. The brain generally takes about 90 minutes to cycle through all four stages and then restarts the process.
READ MORE
Deep sleep and REM help your brain 'heal itself' from fatigue and stress and consolidate memories, said Matthew Pase, an associate professor at the School of Psychological Sciences at Monash University in Melbourne, Australia. In deep sleep, your brain regulates metabolism and hormones; it also acts as a 'rinse' for the brain, clearing out waste. REM is when your brain processes emotions and new information you picked up when you were awake.
[
Why experts believe sleep is as important for survival as food and water
Opens in new window
]
The two phases influence dementia risk in different ways, scientists think.
As part of the rinsing process in deep sleep, your brain flushes out amyloid proteins that are a hallmark of Alzheimer's. Years of interrupted deep sleep and incomplete flushing – known as glymphatic failure – could hasten the onset of dementia, said Dr Maiken Nedergaard, a neurology professor who researches the glymphatic system.
Scientists understand less about how REM is tied to dementia risk, said Dr Roneil Malkani, an associate professor of sleep medicine.
A 2017 study of more than 300 people
over 60 found that a shorter amount of nightly REM sleep, and taking longer to get to the REM phase in each sleep cycle, were both predictors for dementia later in life. That could be because REM is 'vitally important' for storing and processing memories, and losing that capacity both weakens the brain's defences against cognitive decline and can accelerate atrophy in parts of the brain that aren't used, said Dr Pase, who co-wrote the study.
It's also hard to tease out the 'chicken and egg' relationship between sleep and dementia, and whether poor sleep definitively causes it, Dr Pase said. Adults (particularly women) naturally spend less time in deep and REM sleep as they age. Scientists already know ageing itself increases dementia risk, but dementia also tends to worsen sleep. It's possible the two processes 'compound each other,' he said.
Tips for better sleep
Sleep is as important for survival as food and water, says Dr Maria Pertl, health psychology lecturer at the Royal College of Surgeons in Ireland (RCSI). 'If we haven't had a good night's sleep, we can't pay attention to things properly and we have trouble focusing,' she says. 'We tend to be more irritable as our mood fluctuates.'
Dr Maria Pertl.
While Dr Pertl outlines the important physical and mental health benefits of sleep – everything from cell repair to protecting the body from infections, consolidating learning and long term memories – she emphasises how we shouldn't worry if we miss a bit of sleep from time to time. 'Worrying about not getting enough sleep is counterproductive as the body isn't able to relax,' she says. Aiming to rest and not necessarily to get to sleep can be helpful.'
It's generally difficult to target individual stages of sleep for improvement, and as you get older, experts think it may be harder to change the brain's sleep cycles. But there's no downside to improving your sleep hygiene, which is an effective way to boost your sleep overall, including deep and REM sleep, says Dr Malkani.
[
Six things we get wrong about sleep – and how to get better rest, according to experts
Opens in new window
]
Getting about seven hours of sleep a night is the easiest step you can take. That gives your brain enough time to cycle through its stages between four and seven times, he says.
Research has shown that people who sleep six hours or less a night in their 50s, 60s and 70s have a 30 per cent increased risk of dementia later in life, suggesting that it's never too late to improve your sleep, says Bryce Mander, an associate professor of psychiatry and human behaviour.
Having a consistent sleep and wake time can help you fall asleep more easily, says Zsófia Zavecz, a postdoctoral researcher at the Adaptive Brain Lab at the University of Cambridge. What's more, parts of the brain that are used heavily during the day tend to exhibit slower brain waves during sleep, so doing anything that 'meaningfully engages the brain for a while,' such as learning a new skill, could exhaust certain parts and increase their need for restorative, slow-wave sleep, he adds.
Exercising can keep you mentally engaged and increase blood flow to the brain, which is helpful in glymphatic clearance, says Dr Nedergaard. Minimising stress also boosts the process, she adds.
Getting enough sleep
Wearable trackers or smartphone apps can estimate the amount of time you spend in each cycle, but Dr Malkani says it's more helpful to ask yourself: 'How do I feel when I wake up?' And if you wake up in the middle of the night, ask: 'How long did it take me to fall back asleep?'
In general, setting aside enough time to sleep is the best way to ensure your brain reaches deeper stages – and depending on deficits, it may spend more time in REM or deep sleep as it cycles, says Dr Pase. 'Let the brain do its thing, and it will shuffle around as it needs,' he says.
Getting to sleep
Dr Richard Costello, consultant in respiratory and sleep medicine at Beaumont Hospital, Dublin, and professor of respiratory medicine at the Department of Medicine at the RCSI suggests 'sleep restriction' as a counterintuitive tip to getting a good night's sleep. 'It's about not getting into bed and having a fight with yourself about [struggling to get to sleep]. Go to bed when you are really tired and you won't be fretting, tossing and turning in bed,' he says.
Prof Richard Costello.
'Do something dull and repetitive or read a book and then go back to bed,' he says.
Dr Pertl says that listening to a classical fiction audiobook has been a really effective of helping her get to sleep. 'It stops me thinking of things that keep me awake but the quiet, calm voice is not too engaging so I fall asleep quickly.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Irish healthtech firm partners with NHS trusts to improve radiology services
Irish healthtech firm partners with NHS trusts to improve radiology services

Irish Post

timea day ago

  • Irish Post

Irish healthtech firm partners with NHS trusts to improve radiology services

AN Irish healthtech firm will partner with three major NHS trusts to improve access to radiology services for their patients. xWave Technologies has agreed the partnership with the trusts in the Greater Manchester region who will use their clinical decision support (CDS) tool to streamline access to medical imaging procedures. Led by the Greater Manchester Imaging Network, Manchester University NHS Foundation Trust, the Northern Care Alliance NHS Foundation Trust and the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust will all begin rolling out the new scheme, titled GP Direct Access, later this year. It will allow GPs to directly order CT scans of the chest, stomach and hip areas of the body and MRI scans of the brain, in addition to the x-rays and ultrasounds they can already order. Mitchell O'Gorman, CEO at xWave (Pic: Nick Bradshaw) The software provides guidance to doctors in ordering the most appropriate scan for patients as it integrates with the Royal College of Radiologists' iRefer guidelines. 'We're incredibly excited to work with such forward-thinking trusts to deliver clinical decision support at scale,' xWave Technologies CEO Mitchell O'Gorman said. 'At a time when radiology waiting lists are growing and workforce shortages are intensifying, tools like ours can help trusts deliver faster, smarter, and more equitable access to diagnostic imaging.' He added: 'The rollout of xWave's platform comes as NHS England is making additional funding available for NHS trusts that have not yet adopted clinical decision support solutions. 'This funding is intended to support broader adoption of CDS technologies, such as xWave CDS, to reduce unnecessary imaging, alleviate pressure on radiology services, and ensure patients receive timely and accurate diagnoses.' The technology is set to be rolled out across Greater Manchester throughout 2025 and 2026. 'We are delighted to be introducing this innovative technology across three of our NHS Trusts,' Catherine Walsh, Associate Director of the Greater Manchester Imaging Network, said. 'These tools will not only improve outcomes for patients by ensuring they get the right scan at the right time, but they will also support our hardworking GPs and radiology teams by streamlining workflows and optimising use of limited resources,' she added. See More: Greater Manchester, Ireland, Nhs, Radiology, UK, XWave

Top doc recommends getting rid of everyday tool to reduce risk of Alzheimer's
Top doc recommends getting rid of everyday tool to reduce risk of Alzheimer's

Irish Daily Mirror

time2 days ago

  • Irish Daily Mirror

Top doc recommends getting rid of everyday tool to reduce risk of Alzheimer's

There is "such positivity" in Alzheimer's research at the moment, says top immunologist Luke O'Neill. A drug that slows down the disease was recently approved by the European Medicines Agency (EMA), and it is hoped that it will be available in Ireland soon. However, the expert stresses that lifestyle changes can help lower a person's chance of developing the disease. Alzheimer's is the most common form of dementia, which is the umbrella term for memory loss and other cognitive abilities that are serious enough to interfere with daily life. It is primarily caused by the build-up of protein deposits in the brain that eventually kills brain cells. While the exact cause of Alzheimer's is unknown, scientists believe that for most people it is caused by a combination of genetic, lifestyle and environmental factors. In July 2024, the Lancet Commission reported that 45 per cent of dementia cases could be prevented by fully addressing 14 lifestyle factors. Here are Luke O'Neill's and the Lancet's lifestyle recommendations on reducing the risk of Alzheimer's- and it includes ditching a tool most of us use daily. Google Maps is a tool that many of us use daily, however, studies suggest that keeping our brains as active as we can can reduces the risk of Alzheimer's. This can be done by learning a new language, doing puzzles, taking part in quizzes and also by navigating new areas and figuring out directions ourselves. A study published in The BMJ in December 2024 found that taxi drivers and ambulance drivers have the lowest rates of death due to Alzheimer's. Other drivers such as airline pilots or bus drivers - those that have predefined routes - did not have a lower risk of developing the disease. This suggests that occupations requiring frequent navigational and spatial processing could offer some protection against Alzheimer's. Social interaction is a great way to keep the mind active, and scientists have identified social isolation as a risk factor for not only Alzheimer's but hypertension and coronary heart disease. Loneliness can be associated with decreased cognitive activity, which can accelerate cognitive decline and poor mood. Professor O'Neill told the Irish Mirror: "A big one is loneliness, that is a risk factor for developing Alzheimer's and Dementia. We have to mind older people, many older people get isolated and with some encouragement we can hopefully diminish the loneliness epidemic that's there." Studies strongly suggest a link between hearing loss and a higher risk of developing dementia. One found that with every 10-dB decrease in hearing ability, there is a 4 per cent to 24 per cent higher risk of developing dementia. Professor O'Neill encourages everyone to be conscious of their hearing and get it checked if they believe it might be declining. He added: "With a hearing aid you can stave that off, so the big message that's been given in the last while is if you are having trouble hearing go and get a hearing aid because it's a risk of getting Alzheimer's. "These are things we can all do at decreasing our own risk of getting it, and they are very optimistic on that front." The newest Lancet Commission study on dementia reported that high LDL cholesterol is associated with a higher risk of dementia. LDL is commonly known as "bad cholesterol", it's a condition where there's excessive amount of LDL cholesterol in the bloodstream. This is usually checked during a routine bloods appointment, often in a GP office. Luckily, much can be done to reduce LDL cholesterol including a balanced diet low in saturated and trans fats. This is usually found in foods like red meat, full-fat dairy, fried foods and processed snacks. Lifelong learning is associated with improved brain health, with higher levels of cognitive activity. This doesn't mean you have to enroll in a degree programme, but learning a new language or taking up a new skill, even casually, can improve brain health. The Lancet Commission found that those who did not complete secondary school education were more at-risk of developing Alzheimer's. Being active is important for a healthier life, and it has been cited as one of the 14 factors that could reduce the risk of dementia. Physical activity can benefit brain health by reducing chronic inflammation, improving blood flow and increasing the release of protein that is good for brain cells. The World Health Organisation recommends that adults get between 150 and 300 minutes of moderate-intensity aerobic physical activity a week. This would include walking briskly, biking, swimming or dancing. It also recommends that on top of this adults should partake in muscle strengthening activities two times a week. Obesity is also a risk factor for developing Alzheimer's disease. However, it's important to note that BMI is not definitive in diagnosing obesity- as some people can have a high percentage of muscle mass. Calculating body fat percentage, or measuring waist-to-hip ratio can be used to determine a healthy body. An analysis published in the National Library of Medicine with over five million people found that those with higher central obesity - measured by waist-to-hip ratio- was associated with a greater risk of cognitive impairment and dementia.

'Hope on horizon' as new drugs tested for Alzheimer's treatment
'Hope on horizon' as new drugs tested for Alzheimer's treatment

RTÉ News​

time3 days ago

  • RTÉ News​

'Hope on horizon' as new drugs tested for Alzheimer's treatment

Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer's disease. Some 138 new treatments are being assessed for the treatment and prevention of Alzheimer's. A third of drugs currently being trialled are "repurposed" medications that are already being used to tackle other diseases, including diabetes, multiple sclerosis and cholesterol, according to the new review. One such trial is assessing whether semaglutide, the main ingredient for the weight loss and diabetes drug Ozempic and weight loss drug Wegovy, can slow the progression of dementia. And four late-stage trials are looking at preventing disease. Experts said that drugs targeting amyloid protein build up in the brain, such as lecanemab and donanemab, are "only one part of the overall strategy" as they expressed excitement over the variety of new drugs, which are being tested among patients. The new review of Alzheimer's disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs. The number of trials represents an 11% increase on the previous year, according to the review, which was led by an expert from the University of Nevada in the US and has been published in the journal Alzheimer's and Dementia: Translational Research and Clinical Interventions. Commenting on the paper, Dr Sheona Scales, director of research at Alzheimer's Research UK, said: "This year has really given us real cause for optimism." She said that as well as more drugs coming through the pipeline, the treatment targets are "more diverse" and "looking at all stages of the disease". She added: "What this paper is showing us is that the pipeline of drug development is growing, it's diversifying and accelerating." "This latest report shows us that there is hope on the horizon for people with Alzheimer's, building on lecanemab and donanemab." Dr Emma Mead, chief scientific officer of the Oxford Drug Discovery Institute, added: "Today we are at a tipping point in dementia research as we understand more and more about the diseases that drive dementia. "This gives us opportunities to slow and ultimately stop this devastating condition and today's announcement demonstrates that researchers are able to translate these understandings towards potential new treatments." James Rowe, professor of cognitive neurology at the University of Cambridge and consultant neurologist, said: "What strikes me is not just the number of new drugs, which is increasing year on year, but their range of targets (and) the range in which they work, giving us multiple shots on goal." On the drugs which are being investigated for the prevention of disease, Prof Rowe said: "One of the most exciting things of this report is the number of large-scale late-stage trials on prevention. "And the aspiration to prevent, not just treat, is starting to be seen in the figures we see in these charts today." He added: "One way this can work is you take a treatment that you show to be working in people with symptoms with the illness, and then you simply bring it forward by some years. "The ones that are in trial at the moment are really... bringing forward an effective treatment to earlier stage." For instance, people with a genetic risk of Alzheimer's could receive some drugs earlier to see if they protect against the disease. On the repurposing of current drugs, Dr Mead said that it can usually take ten to 15 years for new drugs to be tested and approved for use. "Being able to repurpose drugs licensed for other health conditions could help to accelerate progress and help to open up other avenues to prevent or treat dementia causing diseases," she said. "A really promising example of this is the drug semaglutide, which is currently being trialled in people with mild cognitive impairment." Meanwhile, academics said lecanemab and donanemab, which can be used for treating mild cognitive impairment in Alzheimer's patients, are an "important first step" in the battle against the disease. The treatments were initially approved for UK use by regulators but then deemed not cost-effective for NHS use. The National Institute for Health and Care Excellence (NICE) is taking more evidence on donanemab and lecanemab and is expected to announce its decision in the summer. Dr Scales added: "Lecanemab and donanemab have represented a huge leap forward in our understanding and ability to be able to treat Alzheimer's disease. "What they've done is they've proved that we're able to modify the course of Alzheimer's disease, and what that has done is opened up the door to future treatments that we hope are more effective, easier to deliver and able to deliver for our patients." She said studies are showing "even more complexities" around Alzheimer's and that in the future, people may be treated with a combination of drugs, depending on when they are diagnosed and the type of dementia they have.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store